About
This app provides treatment guidelines for autoimmune diseases, developed by a hospital's internal medicine unit. It offers practical advice on medication dosages, treatment plans, and managing refractory patients for clinicians.
What's New in Autoinmunes
1.0.5
April 9, 2019
Versión de lanzamiento
Developer apps
FAQ
What is Autoinmunes?
Autoinmunes is a free mobile application that provides treatment guidelines for autoimmune diseases, developed by the Autoimmune Diseases Unit of the Hospital Universitario Cruces. It is designed for clinicians who manage patients with these conditions.
Who is Autoinmunes for?
Autoinmunes is intended for clinicians across various specialties, including Internal Medicine, Rheumatology, Dermatology, Nephrology, Hematology, Obstetrics, and Pneumology, who attend to patients with systemic autoimmune diseases.
What kind of information does Autoinmunes offer?
The app details initial glucocorticoid doses, tapering schedules, first and second-line treatments, approaches for refractory patients, and treatment durations, incorporating both general guidelines and clinical experience.
Is Autoinmunes available in English?
Currently, Autoinmunes is available in Spanish and Basque. The app description states that English language support is coming soon.
What are the core principles of treatment in Autoinmunes?
The app emphasizes two basic principles: avoiding high doses of Prednisone for autoimmune diseases and generally using pulses (Methylprednisolone) combined with treatments like antimalarials and immunosuppressants to allow for lower Prednisone doses and quicker reduction.
Is Autoinmunes free to download?
Yes, Autoinmunes is completely free to download and use. It is noted as the first app of its kind to be available for free.
On what devices can I use Autoinmunes?
Autoinmunes is supported on iPhone, iPad, and iPod devices. It is rated for ages 4 and up.
How often is Autoinmunes updated?
The latest version of Autoinmunes is 1.0.5, which was last updated on April 9, 2019. The app was initially released on March 12, 2018.
